Successful treatment of cholesterol crystal embolism with anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody: a case report.
Conclusion: Evolocumab may have a beneficial effect on renal involvement in patients with CCE.
PMID: 32046605 [PubMed - in process]
Source: Renal Failure - Category: Urology & Nephrology Tags: Ren Fail Source Type: research
More News: Cholesterol | Chronic Kidney Disease | Hypertension | Renal Failure | Skin | Skin Biopsy | Urology & Nephrology